Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Eric Jon Jacobsen is active.

Publication


Featured researches published by Eric Jon Jacobsen.


Bioorganic & Medicinal Chemistry Letters | 2010

1-(2-(2,2,2-trifluoroethoxy)ethyl-1H-pyrazolo[4,3-d]pyrimidines as potent phosphodiesterase 5 (PDE5) inhibitors.

Michael B. Tollefson; Brad A. Acker; Eric Jon Jacobsen; Robert O. Hughes; John K. Walker; David Nathan Abraham Fox; Michael John Palmer; Sandra K. Freeman; Ying Yu; Brian R. Bond

1H-Pyrazolo[4,3-d]pyrimidines were previously disclosed as a potent second generation class of phosphodiesterase 5 (PDE5) inhibitors. This work explores the advancement of more selective and potent PDE5 inhibitors resulting from the substitution of 2-(2,2,2-trifluoroethoxy)ethyl at the 1 position in the so-called alkoxy pocket.


Archive | 2003

Fused bicyclic-n-bridged-heteroaromatic carboxamides for the treatment of disease

Bruce N. Rogers; David W. Piotrowski; Daniel P. Walker; Eric Jon Jacobsen; Brad A. Acker; Donn G. Wishka; Vincent E. Groppi


Archive | 2003

Azabicyclic compounds for the treatment of disease

Eric Jon Jacobsen; Jason K. Myers; Daniel P. Walker; Donn G. Wishka; Steven Charles Reitz; David W. Piotrowski; Brad A. Acker; Vincent E. Groppi


Archive | 2002

Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease

Daniel P. Walker; David W. Piotrowski; Eric Jon Jacobsen; Brad A. Acker; Donn G. Wishka; Steven Charles Reitz


Archive | 2002

Azabicyclic-substituted-heteroaryl compounds for the treatment of disease

David W. Piotrowski; Jason K. Myers; Bruce N. Rogers; Eric Jon Jacobsen; Alice L. Bodnar; Vincent E. Groppi; Daniel P. Walker; Brad A. Acker


Archive | 2007

Pyridine[3,4-b]pyrazinones

Robert O. Hughes; Andrew Simon Bell; David Brown; Dafydd R. Owen; Michael John Palmer; Christopher Phillips; David L. Brown; Yvette M. Fobian; John N. Freskos; Steven E. Heasley; Eric Jon Jacobsen; Todd Michael Maddux; Brent V. Mischke; John M. Molyneaux; Joseph B. Moon; Donald Joseph Rogier; Michael B. Tollefson; John K. Walker


Archive | 2002

N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease

Daniel P. Walker; Eric Jon Jacobsen; David W. Piotrowski; Brad A. Acker; Donn G. Wishka; Jeffrey W. Corbett; Mark R. Rauckhorst; Vincent E. Groppi


Bioorganic & Medicinal Chemistry Letters | 2010

1-(2-Ethoxyethyl)-1H-pyrazolo[4,3-d]pyrimidines as potent phosphodiesterase 5 (PDE5) inhibitors

Michael B. Tollefson; Brad A. Acker; Eric Jon Jacobsen; Robert O. Hughes; John K. Walker; David Nathan Abraham Fox; Michael John Palmer; Sandra K. Freeman; Ying Yu; Brian R. Bond


Archive | 2002

Azabicyclic-phenyl-fused-heterocyclic compounds for treatment of disease

Daniel P. Walker; David W. Piotrowski; Eric Jon Jacobsen; Brad A. Acker; Vincent E. Groppi


Archive | 2003

1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease

David W. Piotrowski; Eric Jon Jacobsen; Brad A. Acker; Daniel P. Walker; Donn G. Wishka; Vincent E. Groppi

Researchain Logo
Decentralizing Knowledge